Is a complete HBIO research report available?

No complete published report is available for Harvard Bioscience, Inc. (HBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Harvard Bioscience, Inc. (HBIO)

NASDAQ: HBIO · USD

$8.40

+0.05 (+0.6%)· Recorded snapshot

Market cap	38.2M
Revenue (ttm)	87.8M
Net income (ttm)	-10.4M
EPS (ttm)	-$2.35
Shares out	4.6M
P/E (forward)	46.7x
Volume	5,907
Beta	1.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 87.8M
Net income (ttm): -10.4M
EPS (ttm): -$2.35
P/E (forward): 46.7x
Market cap: 38.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001123494
Company name	Harvard Bioscience, Inc.
Country	United States
Country code	US
CUSIP number	416906204
Earnings date	2026-11-10
Earnings time	bmo
Employees	339
Employees change	-16
Employees growth	-4.51%
Enterprise value	$75.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1901
Industry	Medical Instruments & Supplies
IPO date	2000-12-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US4169062043
Last 10-K release date	2026-03-13
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2026-03-16
Last stock split type	Reverse
Market cap	$38.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$8.40
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	HBIO
U.S. state	Massachusetts
Website	https://www.harvardbioscience.com

Metric

Value

Amount currency

USD

CIK code

0001123494

Company name

Harvard Bioscience, Inc.

Country

United States

Country code

CUSIP number

416906204

Earnings date

2026-11-10

Earnings time

bmo

Employees

339

Employees change

-16

Employees growth

-4.51%

Enterprise value

$75.9M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1901

Industry

Medical Instruments & Supplies

IPO date

2000-12-07

Is primary listing

Yes

Is SPAC

ISIN number

US4169062043

Last 10-K release date

2026-03-13

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split date

2026-03-16

Last stock split type

Reverse

Market cap

$38.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$8.40

Price currency

USD

Sector

Healthcare

SIC code

3826

Stock price date

2026-10-28

Symbol

HBIO

U.S. state

Massachusetts

Website

https://www.harvardbioscience.com

Metric	Value
Earnings yield	-27.96%
EV/EBIT	38.41x
EV/EBITDA	10.27x
EV/Sales	0.86x
FCF / EV yield	-1.48%
FCF yield	-2.94%
Forward EV/Sales	0.82x
Forward P/E	46.67x
Forward P/S	0.41x
Industry forward P/E	22.65x
Industry P/E	75.03x
P/B ratio	5.12x
P/OCF ratio	58.39x
P/S ratio	0.43x
Price/EBITDA ratio	5.16x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-27.96%

EV/EBIT

38.41x

EV/EBITDA

10.27x

EV/Sales

0.86x

FCF / EV yield

-1.48%

FCF yield

-2.94%

Forward EV/Sales

0.82x

Forward P/E

46.67x

Forward P/S

0.41x

Industry forward P/E

22.65x

Industry P/E

75.03x

P/B ratio

5.12x

P/OCF ratio

58.39x

P/S ratio

0.43x

Price/EBITDA ratio

5.16x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	2.24%
EBITDA margin	8.39%
Gross margin	58.16%
Operating margin	2.24%
Pretax margin	-12%
Profit margin	-11.86%
Profit per employee	$-30,714
Revenue per employee	$259,021
ROA	1.58%
ROA (5Y)	-0.18%
ROCE	3.83%
ROE	-89.95%
ROE (5Y)	-36.52%
ROIC	2.23%
SBC / revenue	1.62%
Tax / revenue	-0.15%

Metric

Value

EBIT margin

2.24%

EBITDA margin

8.39%

Gross margin

58.16%

Operating margin

2.24%

Pretax margin

-12%

Profit margin

-11.86%

Profit per employee

$-30,714

Revenue per employee

$259,021

ROA

1.58%

ROA (5Y)

-0.18%

ROCE

3.83%

ROE

-89.95%

ROE (5Y)

-36.52%

ROIC

2.23%

SBC / revenue

1.62%

Tax / revenue

-0.15%

Metric	Value
EPS growth years	0
Gross profit growth	1.05%
Gross profit growth (Q)	9.51%
Gross profit growth 3Y	-7.49%
Gross profit growth 5Y	-4.11%
Net income growth years	0
OCF growth	-90.17%
OCF growth (Q)	-88.2%
OCF growth 10Y	-10.17%
OCF growth 3Y	-57.85%
OCF growth 5Y	-35.63%
Operating income growth 5Y	-14.8%
Revenue growth	-1.06%
Revenue growth (Q)	11.13%
Revenue growth (QoQ)	9.5%
Revenue growth 10Y	-1.98%
Revenue growth 3Y	-8.36%
Revenue growth 5Y	-4.61%
Revenue growth quarters	1
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

1.05%

Gross profit growth (Q)

9.51%

Gross profit growth 3Y

-7.49%

Gross profit growth 5Y

-4.11%

Net income growth years

OCF growth

-90.17%

OCF growth (Q)

-88.2%

OCF growth 10Y

-10.17%

OCF growth 3Y

-57.85%

OCF growth 5Y

-35.63%

Operating income growth 5Y

-14.8%

Revenue growth

-1.06%

Revenue growth (Q)

11.13%

Revenue growth (QoQ)

9.5%

Revenue growth 10Y

-1.98%

Revenue growth 3Y

-8.36%

Revenue growth 5Y

-4.61%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-1.8M
Depreciation and amortization	$5.4M
EBIT	$2M
EBITDA	$7.4M
EPS	$-2.35
FCF per share	$-0.25
Financing cash flow	$1.1M
Free cash flow	$-1.1M
Free cash flow minus SBC	$-2.5M
Gross profit	$51.1M
Income taxes	$-129,000
Investing cash flow	$-2.5M
Net borrowing	$4.7M
Net cash flow	$-939,000
Net income	$-10.4M
Operating cash flow minus SBC	$-769,000
Operating income	$2M
Revenue	$87.8M
Stock-based compensation	$1.4M

Metric

Value

Capital expenditures

$-1.8M

Depreciation and amortization

$5.4M

EBIT

$2M

EBITDA

$7.4M

EPS

$-2.35

FCF per share

$-0.25

Financing cash flow

$1.1M

Free cash flow

$-1.1M

Free cash flow minus SBC

$-2.5M

Gross profit

$51.1M

Income taxes

$-129,000

Investing cash flow

$-2.5M

Net borrowing

$4.7M

Net cash flow

$-939,000

Net income

$-10.4M

Operating cash flow minus SBC

$-769,000

Operating income

$2M

Revenue

$87.8M

Stock-based compensation

$1.4M

Metric	Value
Altman Z-Score	-2.26
Book value per share	$1.63
Debt / EBITDA	4.52
Debt / equity	5.96
Goodwill	$9.3M
Interest coverage	0.3
Long-term assets	$29.8M
Long-term liabilities	$44.1M
Net cash (debt)	$-37.7M
Net cash / market cap	-99.19%
Net debt / EBITDA	5.12
Net debt / equity	5.08
Piotroski F-Score	6
Property, plant and equipment	$11.7M
Shareholders' equity	$7.4M
Tangible book value	$-8.1M
Tangible book value per share	$-1.79
Total assets	$76.3M
Total cash	$6.5M
Total debt	$44.2M
Total liabilities	$68.9M
WACC	12.05%

Metric

Value

Altman Z-Score

-2.26

Book value per share

$1.63

Debt / EBITDA

4.52

Debt / equity

5.96

Goodwill

$9.3M

Interest coverage

0.3

Long-term assets

$29.8M

Long-term liabilities

$44.1M

Net cash (debt)

$-37.7M

Net cash / market cap

-99.19%

Net debt / EBITDA

5.12

Net debt / equity

5.08

Piotroski F-Score

Property, plant and equipment

$11.7M

Shareholders' equity

$7.4M

Tangible book value

$-8.1M

Tangible book value per share

$-1.79

Total assets

$76.3M

Total cash

$6.5M

Total debt

$44.2M

Total liabilities

$68.9M

WACC

12.05%

Metric	Value
Asset turnover	1.12
Current assets	$46.5M
Current liabilities	$24.8M
Current ratio	1.87
Inventory turnover	1.65
Net working capital	$16.8M
Quick ratio	0.85
Working capital	$21.7M
Working capital turnover	15.36

Metric

Value

Asset turnover

1.12

Current assets

$46.5M

Current liabilities

$24.8M

Current ratio

1.87

Inventory turnover

1.65

Net working capital

$16.8M

Quick ratio

0.85

Working capital

$21.7M

Working capital turnover

15.36

Metric	Value
Buyback yield / dilution	-1.81%
Dividend yield	0%
Shareholder yield	-1.81%

Metric

Value

Buyback yield / dilution

-1.81%

Dividend yield

Shareholder yield

-1.81%

Metric	Value
10Y price change	-63.78%
10Y return CAGR	-9.66%
10Y total return	-63.78%
150-day SMA	$6.71
15Y price change	-82.28%
15Y return CAGR	-9.23%
15Y total return	-76.61%
1D price change	0.6%
1M price change	4.65%
1M total return	4.65%
1W price change	-0.12%
1W total return	-0.12%
1Y price change	107.21%
1Y return CAGR	107.32%
1Y total return	107.21%
20-day SMA	$8.30
200-day SMA	$6.41
20Y price change	-82.9%
20Y return CAGR	-7.17%
20Y total return	-77.42%
3M price change	39.07%
3M total return	39.07%
3Y price change	-80.67%
3Y return CAGR	-42.18%
3Y total return	-80.67%
50-day SMA	$8.06
50-day SMA vs 200-day SMA	50over200
52-week high	$9.40
52-week high date	2025-10-30
52-week low	$3.97
52-week low date	2025-10-28
5Y price change	-88.12%
5Y return CAGR	-34.69%
5Y total return	-88.12%
6M price change	21.96%
6M total return	21.96%
All-time high	$145.00
All-time high date	2001-09-04
All-time low	$2.81
All-time low date	2025-05-28
Average true range (ATR)	$0.29
Average volume	15.6K
Beta (1Y)	1.89
Beta (2Y)	2.18
Beta (5Y)	1.51
Change from 52-week high	-10.64%
Change from 52-week low	111.85%
Change from all-time high	-94.26%
Change from all-time low	196.13%
Change from open	0.6%
Day's gap	0%
Dollar volume	$49,619
High price	$8.48
Low price	$8.13
Monthly RSI	40.77
Open price	$8.35
Position in 52-week range	77.14%
Premarket change	1.92%
Premarket close	$8.35
Premarket price	$8.51
Previous close	$8.35
Price vs 150-day SMA	24.24%
Price vs 20-day SMA	0.39%
Price vs 200-day SMA	30.03%
Price vs 50-day SMA	3.36%
Relative volume	0.38
RSI	55.41
Sharpe ratio	1.21
Sharpe ratio (3Y)	-0.06
Sharpe ratio (5Y)	-0.09
Sortino ratio	2.12
Sortino ratio (3Y)	-0.05
Sortino ratio (5Y)	-0.1
Volume	5.9K
Weekly RSI	65.6
YTD price change	24.55%
YTD total return	24.55%

Metric

Value

10Y price change

-63.78%

10Y return CAGR

-9.66%

10Y total return

-63.78%

150-day SMA

$6.71

15Y price change

-82.28%

15Y return CAGR

-9.23%

15Y total return

-76.61%

1D price change

0.6%

1M price change

4.65%

1M total return

4.65%

1W price change

-0.12%

1W total return

-0.12%

1Y price change

107.21%

1Y return CAGR

107.32%

1Y total return

107.21%

20-day SMA

$8.30

200-day SMA

$6.41

20Y price change

-82.9%

20Y return CAGR

-7.17%

20Y total return

-77.42%

3M price change

39.07%

3M total return

39.07%

3Y price change

-80.67%

3Y return CAGR

-42.18%

3Y total return

-80.67%

50-day SMA

$8.06

50-day SMA vs 200-day SMA

50over200

52-week high

$9.40

52-week high date

2025-10-30

52-week low

$3.97

52-week low date

2025-10-28

5Y price change

-88.12%

5Y return CAGR

-34.69%

5Y total return

-88.12%

6M price change

21.96%

6M total return

21.96%

All-time high

$145.00

All-time high date

2001-09-04

All-time low

$2.81

All-time low date

2025-05-28

Average true range (ATR)

$0.29

Average volume

15.6K

Beta (1Y)

1.89

Beta (2Y)

2.18

Beta (5Y)

1.51

Change from 52-week high

-10.64%

Change from 52-week low

111.85%

Change from all-time high

-94.26%

Change from all-time low

196.13%

Change from open

0.6%

Day's gap

Dollar volume

$49,619

High price

$8.48

Low price

$8.13

Monthly RSI

40.77

Open price

$8.35

Position in 52-week range

77.14%

Premarket change

1.92%

Premarket close

$8.35

Premarket price

$8.51

Previous close

$8.35

Price vs 150-day SMA

24.24%

Price vs 20-day SMA

0.39%

Price vs 200-day SMA

30.03%

Price vs 50-day SMA

3.36%

Relative volume

0.38

RSI

55.41

Sharpe ratio

1.21

Sharpe ratio (3Y)

-0.06

Sharpe ratio (5Y)

-0.09

Sortino ratio

2.12

Sortino ratio (3Y)

-0.05

Sortino ratio (5Y)

-0.1

Volume

5.9K

Weekly RSI

65.6

YTD price change

24.55%

YTD total return

24.55%

Metric	Value
Float	3.7M
Float percentage	80.77%
Shares change (QoQ)	1.18%
Shares change (YoY)	1.81%
Shares held by insiders	7.12%
Shares held by institutions	30.1%
Shares outstanding	4.6M
Short % of float	1.36%
Short % of shares	1.1%
Short ratio	2.4 days

Metric

Value

Float

3.7M

Float percentage

80.77%

Shares change (QoQ)

1.18%

Shares change (YoY)

1.81%

Shares held by insiders

7.12%

Shares held by institutions

30.1%

Shares outstanding

4.6M

Short % of float

1.36%

Short % of shares

1.1%

Short ratio

2.4 days

Harvard Bioscience, Inc. (HBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · HBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HBIO

Frequently asked questions